Paycom Software, Inc. (PAYC)
NYSE: PAYC · Real-Time Price · USD
226.80
-3.05 (-1.33%)
Aug 11, 2025, 11:03 AM - Market open
Oncternal Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 1,842 | 1,758 | 1,586 | 1,343 | 1,056 | 841.43 | Upgrade |
Other Revenue | 118.1 | 124.9 | 108 | 32.7 | - | - | Upgrade |
| 1,960 | 1,883 | 1,694 | 1,375 | 1,056 | 841.43 | Upgrade | |
Revenue Growth (YoY) | 10.21% | 11.19% | 23.16% | 30.29% | 25.44% | 14.07% | Upgrade |
Cost of Revenue | 271.1 | 267.4 | 223.7 | 169.8 | 130.48 | 97.78 | Upgrade |
Gross Profit | 1,689 | 1,616 | 1,470 | 1,205 | 925.05 | 743.66 | Upgrade |
Selling, General & Admin | 828.9 | 710.5 | 705.7 | 585.7 | 485.83 | 413.92 | Upgrade |
Research & Development | 266.8 | 242.6 | 199 | 148.3 | 118.43 | 90.24 | Upgrade |
Operating Expenses | 1,255 | 1,099 | 1,019 | 826.7 | 671.48 | 557.53 | Upgrade |
Operating Income | 433.4 | 516.8 | 451.3 | 378.7 | 253.57 | 186.12 | Upgrade |
Interest Expense | -3.4 | -3.4 | -1.9 | -2.5 | - | -0.02 | Upgrade |
Other Non Operating Income (Expenses) | 18.5 | 18.1 | 24.2 | 13.2 | 2.54 | -0.17 | Upgrade |
EBT Excluding Unusual Items | 449.8 | 531.5 | 473.6 | 389.4 | 256.11 | 185.94 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.2 | -0.15 | - | Upgrade |
Other Unusual Items | 117.5 | 117.5 | -1.2 | - | - | - | Upgrade |
Pretax Income | 567.3 | 649 | 472.4 | 389.6 | 255.96 | 185.94 | Upgrade |
Income Tax Expense | 151.6 | 147 | 131.6 | 108.2 | 60 | 42.48 | Upgrade |
Net Income | 415.7 | 502 | 340.8 | 281.4 | 195.96 | 143.45 | Upgrade |
Net Income to Common | 415.7 | 502 | 340.8 | 281.4 | 195.96 | 143.45 | Upgrade |
Net Income Growth | -11.96% | 47.30% | 21.11% | 43.60% | 36.60% | -20.56% | Upgrade |
Shares Outstanding (Basic) | 56 | 56 | 58 | 58 | 58 | 58 | Upgrade |
Shares Outstanding (Diluted) | 56 | 56 | 58 | 58 | 58 | 58 | Upgrade |
Shares Change (YoY) | -1.85% | -2.93% | -0.34% | 0.01% | -0.16% | -0.19% | Upgrade |
EPS (Basic) | 7.43 | 8.93 | 5.91 | 4.86 | 3.39 | 2.49 | Upgrade |
EPS (Diluted) | 7.40 | 8.92 | 5.88 | 4.84 | 3.37 | 2.46 | Upgrade |
EPS Growth | -10.22% | 51.70% | 21.49% | 43.62% | 36.99% | -20.41% | Upgrade |
Free Cash Flow | 359.2 | 341 | 292.4 | 232.4 | 198.67 | 133.11 | Upgrade |
Free Cash Flow Per Share | 6.39 | 6.06 | 5.04 | 3.99 | 3.41 | 2.28 | Upgrade |
Dividend Per Share | 1.500 | 1.500 | 1.125 | - | - | - | Upgrade |
Dividend Growth | - | 33.33% | - | - | - | - | Upgrade |
Gross Margin | 86.17% | 85.80% | 86.79% | 87.65% | 87.64% | 88.38% | Upgrade |
Operating Margin | 22.11% | 27.44% | 26.65% | 27.54% | 24.02% | 22.12% | Upgrade |
Profit Margin | 21.21% | 26.66% | 20.12% | 20.46% | 18.57% | 17.05% | Upgrade |
Free Cash Flow Margin | 18.33% | 18.11% | 17.26% | 16.90% | 18.82% | 15.82% | Upgrade |
EBITDA | 510 | 579.6 | 503.3 | 424.1 | 284.29 | 212.4 | Upgrade |
EBITDA Margin | 26.02% | 30.78% | 29.72% | 30.84% | 26.93% | 25.24% | Upgrade |
D&A For EBITDA | 76.6 | 62.8 | 52 | 45.4 | 30.72 | 26.27 | Upgrade |
EBIT | 433.4 | 516.8 | 451.3 | 378.7 | 253.57 | 186.12 | Upgrade |
EBIT Margin | 22.11% | 27.44% | 26.65% | 27.54% | 24.02% | 22.12% | Upgrade |
Effective Tax Rate | 26.72% | 22.65% | 27.86% | 27.77% | 23.44% | 22.85% | Upgrade |
Revenue as Reported | 1,960 | 1,883 | 1,694 | 1,375 | 1,056 | 841.43 | Upgrade |
Advertising Expenses | - | 86.3 | 106.8 | 90.6 | 71.6 | 66.9 | Upgrade |
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.